Durbin AP - Search Results

1

Heterotypic dengue infection with live attenuated monotypic dengue virus vaccines: implications for vaccination of populations in areas where dengue is endemic.

Durbin AP, Schmidt A, Elwood D, Wanionek KA, Lovchik J, Thumar B, Murphy BR, Whitehead SS. Durbin AP, et al. J Infect Dis. 2011 Feb 1;203(3):327-34. doi: 10.1093/infdis/jiq059. Epub 2010 Dec 14. J Infect Dis. 2011. PMID: 21208923 Free PMC article. Clinical Trial.

2

Minimum protein requirements for transcription and RNA replication of a minigenome of human parainfluenza virus type 3 and evaluation of the rule of six.

Durbin AP, Siew JW, Murphy BR, Collins PL. Durbin AP, et al. Virology. 1997 Jul 21;234(1):74-83. doi: 10.1006/viro.1997.8633. Virology. 1997. PMID: 9234948 Free article.

3

Recovery of infectious human parainfluenza virus type 3 from cDNA.

Durbin AP, Hall SL, Siew JW, Whitehead SS, Collins PL, Murphy BR. Durbin AP, et al. Virology. 1997 Sep 1;235(2):323-32. doi: 10.1006/viro.1997.8697. Virology. 1997. PMID: 9281512 Free article.

4

Three amino acid substitutions in the L protein of the human parainfluenza virus type 3 cp45 live attenuated vaccine candidate contribute to its temperature-sensitive and attenuation phenotypes.

Skiadopoulos MH, Durbin AP, Tatem JM, Wu SL, Paschalis M, Tao T, Collins PL, Murphy BR. Skiadopoulos MH, et al. Among authors: durbin ap. J Virol. 1998 Mar;72(3):1762-8. doi: 10.1128/JVI.72.3.1762-1768.1998. J Virol. 1998. PMID: 9499025 Free PMC article.

5

Recovery of a fully viable chimeric human parainfluenza virus (PIV) type 3 in which the hemagglutinin-neuraminidase and fusion glycoproteins have been replaced by those of PIV type 1.

Tao T, Durbin AP, Whitehead SS, Davoodi F, Collins PL, Murphy BR. Tao T, et al. Among authors: durbin ap. J Virol. 1998 Apr;72(4):2955-61. doi: 10.1128/JVI.72.4.2955-2961.1998. J Virol. 1998. PMID: 9525616 Free PMC article.

6

The immunogenicity and efficacy of intranasally or parenterally administered replication-deficient vaccinia-parainfluenza virus type 3 recombinants in rhesus monkeys.

Durbin AP, Wyatt LS, Siew J, Moss B, Murphy BR. Durbin AP, et al. Vaccine. 1998 Aug;16(13):1324-30. doi: 10.1016/s0264-410x(98)00010-3. Vaccine. 1998. PMID: 9682397

7

Identification of mutations contributing to the temperature-sensitive, cold-adapted, and attenuation phenotypes of the live-attenuated cold-passage 45 (cp45) human parainfluenza virus 3 candidate vaccine.

Skiadopoulos MH, Surman S, Tatem JM, Paschalis M, Wu SL, Udem SA, Durbin AP, Collins PL, Murphy BR. Skiadopoulos MH, et al. Among authors: durbin ap. J Virol. 1999 Feb;73(2):1374-81. doi: 10.1128/JVI.73.2.1374-1381.1999. J Virol. 1999. PMID: 9882342 Free PMC article.

8

A live attenuated chimeric recombinant parainfluenza virus (PIV) encoding the internal proteins of PIV type 3 and the surface glycoproteins of PIV type 1 induces complete resistance to PIV1 challenge and partial resistance to PIV3 challenge.

Tao T, Skiadopoulos MH, Durbin AP, Davoodi F, Collins PL, Murphy BR. Tao T, et al. Among authors: durbin ap. Vaccine. 1999 Mar 5;17(9-10):1100-8. doi: 10.1016/s0264-410x(98)00327-2. Vaccine. 1999. PMID: 10195620

This was used to recover a fully-viable, recombinant chimeric PIV3-PIV1 virus, termed rPIV3-1, which bears the major protective antigens of PIV1 and is wild type-like with regard to growth in cell culture and in hamsters [Tao T, Durbin AP, Whitehead SS, Davoodi F, C …

This was used to recover a fully-viable, recombinant chimeric PIV3-PIV1 virus, termed rPIV3-1, which bears the major protective antigens of …

9

Comparison of the immunogenicity and efficacy of a replication-defective vaccinia virus expressing antigens of human parainfluenza virus type 3 (HPIV3) with those of a live attenuated HPIV3 vaccine candidate in rhesus monkeys passively immunized with PIV3 antibodies.

Durbin AP, Cho CJ, Elkins WR, Wyatt LS, Moss B, Murphy BR. Durbin AP, et al. J Infect Dis. 1999 Jun;179(6):1345-51. doi: 10.1086/314769. J Infect Dis. 1999. PMID: 10228053

10

Mutations in the C, D, and V open reading frames of human parainfluenza virus type 3 attenuate replication in rodents and primates.

Durbin AP, McAuliffe JM, Collins PL, Murphy BR. Durbin AP, et al. Virology. 1999 Sep 1;261(2):319-30. doi: 10.1006/viro.1999.9878. Virology. 1999. PMID: 10497117 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

177 results

Search Page

Filters